Blog Details

Novo Nordisk sues Eli Lilly over ads comparing GLP-1 medications

Novo Nordisk sues Eli Lilly over ads comparing GLP-1 medications

The Danish company Novo says U.S.-based Lilly isn’t including the most up-to-date clinical information about its drugs.

Read the full article on MarketWatch ?

Start Trading Today

Join thousands of traders and investors. Discover how specific trading strategies work — and get started with your investment journey.